Predicting Outcomes of Atezolizumab and Bevacizumab Treatment in Patients with Hepatocellular Carcinoma

被引：12

作者：

Han, Ji Won ^{[1
,2
]}

Jang, Jeong Won ^{[1
,2
]}

机构：

[1] Catholic Univ Korea, Catholic Univ Liver Res Ctr, Coll Med, Seoul 06591, South Korea

[2] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Gastroenterol & Hepatol, Seoul 06591, South Korea

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 14期

基金：

新加坡国家研究基金会;

关键词：

hepatocellular carcinoma; atezolizmumab-bevacizumab; biomarker; NEUTROPHIL-LYMPHOCYTE RATIO; PLUS BEVACIZUMAB; TUMOR; EXPRESSION; CELLS; INTERLEUKIN-6; MULTICENTER; COMBINATION; SUPPRESSION; SORAFENIB;

D O I：

10.3390/ijms241411799

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A combination of atezolizumab with bevacizumab (AB) is the first regimen that has shown superiority compared to sorafenib and is now being used as the systemic treatment of choice for hepatocellular carcinoma (HCC) patients with Barcelona Liver Cancer Clinic stage C. However, a considerable number of patients do not achieve survival or significant responses, indicating the need to identify predictive biomarkers for initial and on-treatment decisions in HCC patients receiving AB. In this manuscript, we summarized the current data from both experimental and clinical studies. This review will be beneficial for both clinicians and researchers in clinical practice as well as those designing experimental, translational, or clinical studies.

引用

页数：22

共 50 条

[31] Atezolizumab plus bevacizumab in advanced hepatocellular carcinoma after treatment failure with multikinase inhibitors [J].

Haghnejad, Vincent ;

Muller, Marie ;

Blaise, Lorraine ;

Gerolami, Rene ;

Bouattour, Mohamed ;

Assenat, Eric ;

Manfredi, Sylvain ;

Peron, Jean-Marie ;

Burcheri-Curatolo, Adriano ;

Lopez, Anthony ;

Ressiot, Emmnanuelle ;

Nahon, Pierre ;

Bronowicki, Jean-Pierre .

DIGESTIVE AND LIVER DISEASE, 2023, 55 (07) :938-944

[32] Current Role of Atezolizumab Plus Bevacizumab Therapy in the Sequential Treatment of Unresectable Hepatocellular Carcinoma [J].

Komatsu, Shohei ;

Yano, Yoshihiko ;

Fujishima, Yoshimi ;

Ishida, Jun ;

Kido, Masahiro ;

Kuramitsu, Kaori ;

Yamamoto, Atsushi ;

Goto, Tadahiro ;

Yanagimoto, Hiroaki ;

Toyama, Hirochika ;

Ueda, Yoshihide ;

Kodama, Yuzo ;

Fukumoto, Takumi .

ANTICANCER RESEARCH, 2022, 42 (03) :1403-1412

[33] Real-World Systemic Treatment Patterns after Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma in the United States [J].

Singal, Amit G. ;

Ozgurdal, Kirhan ;

Fan, Xiaozhou ;

Vassilev, Zdravko ;

Pan, Xiaoyun ;

Multani, Jasjit K. ;

Chen, Chi-Chang ;

Zhou, Zifan ;

He, Jing ;

Pisa, Federica .

CANCERS, 2023, 15 (23)

[34] Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma [J].

Yang, Zijian ;

Suda, Goki ;

Maehara, Osamu ;

Ohara, Masatsugu ;

Yoda, Tomoka ;

Sasaki, Takashi ;

Kohya, Risako ;

Yoshida, Sonoe ;

Hosoda, Shunichi ;

Tokuchi, Yoshimasa ;

Kitagataya, Takashi ;

Suzuki, Kazuharu ;

Kawagishi, Naoki ;

Nakai, Masato ;

Sho, Takuya ;

Natsuizaka, Mitsuteru ;

Ogawa, Koji ;

Ohnishi, Shunsuke ;

Sakamoto, Naoya .

CANCERS, 2023, 15 (03)

[35] Efficacy and safety of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients with esophageal-gastric varices [J].

Tada, Fujimasa ;

Hiraoka, Atsushi ;

Tada, Toshifumi ;

Hirooka, Masashi ;

Kariyama, Kazuya ;

Tani, Joji ;

Atsukawa, Masanori ;

Takaguchi, Koichi ;

Itobayashi, Ei ;

Fukunishi, Shinya ;

Tsuji, Kunihiko ;

Ishikawa, Toru ;

Tajiri, Kazuto ;

Ochi, Hironori ;

Toyoda, Hidenori ;

Ogawa, Chikara ;

Nishimura, Takashi ;

Hatanaka, Takeshi ;

Kakizaki, Satoru ;

Shimada, Noritomo ;

Kawata, Kazuhito ;

Naganuma, Atsushi ;

Kosaka, Hisashi ;

Matono, Tomomitsu ;

Kuroda, Hidekatsu ;

Yata, Yutaka ;

Ohama, Hideko ;

Nouso, Kazuhiro ;

Morishita, Asahiro ;

Tsutsui, Akemi ;

Nagano, Takuya ;

Itokawa, Norio ;

Okubo, Tomomi ;

Arai, Taeang ;

Yokohama, Keisuke ;

Nishikawa, Hiroki ;

Imai, Michitaka ;

Koizumi, Yohei ;

Nakamura, Shinichiro ;

Iijima, Hiroko ;

Kaibori, Masaki ;

Hiasa, Yoichi ;

Kumada, Takashi .

JOURNAL OF GASTROENTEROLOGY, 2023, 58 (11) :1134-1143

[36] The potential efficacy of atezolizumab plus bevacizumab treatment for hepatocellular carcinoma patients with macroscopic portal vein tumor thrombus [J].

Komatsu, Shohei ;

Yano, Yoshihiko ;

Terashima, Kazuki ;

Fujishima, Yoshimi ;

Ishida, Jun ;

Ishihara, Nobuaki ;

Matsuura, Takanori ;

Okimoto, Tomoaki ;

Kodama, Yuzo ;

Fukumoto, Takumi .

SURGERY TODAY, 2025, 55 (07) :900-908

[37] Safety and efficacy of atezolizumab/bevacizumab in unresectable hepatocellular carcinoma-a multicentric study [J].

Babu, Merin ;

Komaranchath, Ashok Sebastian ;

Valsan, Arun ;

Warrier, Arun R. ;

Mp, Rakesh ;

Jose, Wesley M. ;

Haridas, Nikhil K. ;

Soman, Sumi ;

Nair, Manjima P. ;

Sadasivan, Shine ;

Menon, Abhinav ;

Thabrez, Mohammed ;

Pavithran, Keechilat .

BMC CANCER, 2025, 25 (01)

[38] Thyroid Dysfunction After Atezolizumab and Bevacizumab is Associated with Favorable Outcomes in Hepatocellular Carcinoma [J].

Song, Young Shin ;

Yang, Hannah ;

Kang, Beodeul ;

Cheon, Jaekyung ;

Kim, Ilhwan ;

Kim, Hyeyeong ;

Lee, Won Suk ;

Sang, Yun Beom ;

Jung, Sanghoon ;

Lim, Ho Yeong ;

Gaillard, Vincent E. ;

Kim, Chan ;

Chon, Hong Jae .

LIVER CANCER, 2024, 13 (01) :89-98

[39] Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysis [J].

Hatanaka, Takeshi ;

Hiraoka, Atsushi ;

Tada, Toshifumi ;

Hirooka, Masashi ;

Kariyama, Kazuya ;

Tani, Joji ;

Atsukawa, Masanori ;

Takaguchi, Koichi ;

Itobayashi, Ei ;

Fukunishi, Shinya ;

Tsuji, Kunihiko ;

Ishikawa, Toru ;

Tajiri, Kazuto ;

Ochi, Hironori ;

Yasuda, Satoshi ;

Toyoda, Hidenori ;

Ogawa, Chikara ;

Nishimura, Takashi ;

Kakizaki, Satoru ;

Shimada, Noritomo ;

Kawata, Kazuhito ;

Tanaka, Takaaki ;

Ohama, Hideko ;

Nouso, Kazuhiro ;

Morishita, Asahiro ;

Tsutsui, Akemi ;

Nagano, Takuya ;

Itokawa, Norio ;

Okubo, Tomomi ;

Arai, Taeang ;

Imai, Michitaka ;

Naganuma, Atsushi ;

Koizumi, Yohei ;

Nakamura, Shinichiro ;

Joko, Kouji ;

Iijima, Hiroko ;

Hiasa, Yoichi ;

Kumada, Takashi .

HEPATOLOGY RESEARCH, 2022, 52 (05) :462-470

[40] A Case of Pseudoprogression in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab [J].

Watanabe, Yukinobu ;

Ogawa, Masahiro ;

Tamura, Yu ;

Suda, Seiichiro ;

Kaneko, Masahiro ;

Kumagawa, Mariko ;

Hirayama, Midori ;

Matsumoto, Naoki ;

Yamamoto, Toshiki ;

Moriyama, Mitsuhiko .

JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2021, 9

← 1 2 3 4 5 →